Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial
Ali Saeedi‐Boroujeni, Roohangiz Nashibi, Ata Ghadiri, et al.
Archives of Medical Research (2022) Vol. 53, Iss. 4, pp. 368-377
Open Access | Times Cited: 19

Showing 19 citing articles:

New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation
Triveni Kodi, Runali Sankhe, Adarsh Gopinathan, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 22
The double sides of NLRP3 inflammasome activation in sepsis
C. Vigneron, Bénédicte F. Py, Guillaume Monneret, et al.
Clinical Science (2023) Vol. 137, Iss. 5, pp. 333-351
Closed Access | Times Cited: 18
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Posttranslational modifications of NLRP3 and their regulatory roles in inflammasome activation
Ying Qin, Wei Zhao
European Journal of Immunology (2023) Vol. 53, Iss. 10
Open Access | Times Cited: 13
Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition
Noemí Cárdenas‐Rodríguez, Iván Ignacio‐Mejía, José Correa‐Basurto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3805-3805
Open Access | Times Cited: 4
Differential activation of programmed cell death in patients with severe SARS-CoV-2 infection
Ashleigh N. Riegler, Paul V. Benson, Kenneth D. Long, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence
Izabela Bolesławska, Magdalena Kowalówka, Natasza Bolesławska-Król, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1262-1262
Open Access | Times Cited: 8
Role of Damage-Associated Molecular Patterns (DAMPS) in the Postoperative Period after Colorectal Surgery
María José Caballero-Herrero, Esther Jumilla, Manuel Buitrago-Ruiz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3862-3862
Open Access | Times Cited: 7
How to Restore Oxidative Balance That Was Disrupted by SARS-CoV-2 Infection
Kajetan Kiełbowski, Mariola Herian, Andrzej Pawlik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6377-6377
Open Access | Times Cited: 9
Lessons Learned From Clinical Trials of Immunotherapeutics for COVID‐19
Ickjai Lee, Christopher Lupfer
Immunological Reviews (2024)
Closed Access | Times Cited: 1
Race between virus and inflammasomes: inhibition or escape, intervention and therapy
Nijin Wu, Chunzhi Zheng, Jiarui Xu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Comparing the expression of MiR-223-NLRP3-IL-1β axis and serum IL-1β levels in patients with severe COVID-19 and healthy individuals
Sheyda Houshmandfar, Ali Khodadadi, Mohammad‐Reza Mahmoudian‐Sani, et al.
Immunobiology (2023) Vol. 228, Iss. 5, pp. 152710-152710
Closed Access | Times Cited: 4
Different Anti-inflammatory Drugs on High-Sensitivity C-Reactive Protein in Patients After Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial
Miao Yu, Zhengfeng Zhu, Fen Yang, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 83, Iss. 3, pp. 234-242
Closed Access | Times Cited: 4
Utility of a novel turn-off fluorescence probe for the determination of tranilast, an adjunctive drug for patients with severe COVID-19
Diaa Dagher, Heba Elmansi, Jenny Jeehan Nasr, et al.
RSC Advances (2022) Vol. 12, Iss. 34, pp. 22044-22053
Open Access | Times Cited: 7
Carboxylic Acid O–H Insertion Reaction of β-Ester Diazos Enabling Synthesis of β-Acyloxy Esters
Ziyi Li, Xinyu Yao, Xin Zhang, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 22, pp. 15483-15491
Closed Access | Times Cited: 6
COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine
Irina Vlasova-St. Louis, Daniel Fang, Yara Amer, et al.
Reports — Medical Cases Images and Videos (2023) Vol. 6, Iss. 4, pp. 45-45
Open Access | Times Cited: 3
Pyroptosis in microbial infectious diseases
Xiao Cui, Saihong Cao, Yunfei Li, et al.
Molecular Biology Reports (2023) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
COVID-19 in Relation to Chronic Antihistamine Prescription
Anna Puigdellı́vol-Sánchez, Marta Juanes-González, Ana Calderón-Valdiviezo, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2589-2589
Open Access
Differential Activation of Programmed Cell Death in Patients with Severe SARS-CoV-2 Infection
Ashligh Riegler, Paul V. Benson, Kenneth D. Long, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top